Related references
Note: Only part of the references are listed.Genistein: Its role in metabolic diseases and cancer
Vidya Mukund et al.
CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY (2017)
ME-143 Is Superior to Genistein in Suppression of WNT Signaling in Colon Cancer Cells
Sofya Pintova et al.
ANTICANCER RESEARCH (2017)
Genistein and Cancer: Current Status, Challenges, and Future Directions
Carmela Spagnuolo et al.
ADVANCES IN NUTRITION (2015)
A first-in-human dose-escalation study of ME-143, a second generation NADH oxidase inhibitor, in patients with advanced solid tumors
Shubham Pant et al.
INVESTIGATIONAL NEW DRUGS (2014)
Update on genistein and thyroid: an overall message of safety
Herbert Marini et al.
FRONTIERS IN ENDOCRINOLOGY (2012)
Genistein attenuates WNT signaling by up-regulating sFRP2 in a human colon cancer cell line
Yukun Zhang et al.
EXPERIMENTAL BIOLOGY AND MEDICINE (2011)
Factors Related to the Use of Dietary Supplements by Cancer Survivors
Leah M. Ferrucci et al.
JOURNAL OF ALTERNATIVE AND COMPLEMENTARY MEDICINE (2009)
Bevacizumab in combination with oxaliplatin-based chemotherapy as first-line therapy in metastatic colorectal cancer:: A randomized phase III study
Leonard B. Saltz et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Sensitization of ovarian cancer cells to cisplatin by genistein: the role of NF-kappaB
Leigh A Solomon et al.
Journal of Ovarian Research (2008)
Repeated oral once daily intake of increasing doses of the novel synthetic genistein product Bonistein™ in healthy volunteers
U Ullmann et al.
PLANTA MEDICA (2005)
Is voluntary vitamin and mineral supplementation associated with better outcome in non-small cell lung cancer patients? Results from the Mayo Clinic lung cancer cohort
A Jatoi et al.
LUNG CANCER (2005)
Combination of 5-fluorouracil and genistein induces apoptosis synergistically in chemo-resistant cancer cells through the modulation of AMPK and COX-2 signaling pathways
JT Hwang et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2005)
Safety, tolerability, and pharmacokinetics of single ascending doses of synthetic genistein (Bonistein (TM)) in healthy volunteers
U Ullmann et al.
ADVANCES IN THERAPY (2005)
Clinical characteristics and pharmacokinetics of purified soy isoflavones: Multiple-dose administration to men with prostate neoplasia
L Fischer et al.
NUTRITION AND CANCER-AN INTERNATIONAL JOURNAL (2004)
Comparing the pharmacokinetics of daidzein and genistein with the use of 13C-labeled tracers in premenopausal women
KDR Setchell et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2003)
Clinical characteristics and pharmacokinetics of purified soy isoflavones: single-dose administration to healthy men
MG Busby et al.
AMERICAN JOURNAL OF CLINICAL NUTRITION (2002)